What is NCT04512345 (aminolevulinic acid hydrochloride) and what kind of trial is it?
NCT04512345 is a clinical study registered on ClinicalTrials.gov that involves aminolevulinic acid hydrochloride. The “intervention type” for this trial is based on the trial’s designation under ClinicalTrials.gov, which typically categorizes the study by how the investigational or active treatment is used (for example, whether it is being given as an investigational drug, as a treatment compared against another approach, or as part of a procedural/therapy protocol).
However, the provided question does not include the trial’s intervention-type field text, and I do not have the trial record details needed to state the exact intervention type wording for NCT04512345.
What you can check on ClinicalTrials.gov to confirm the exact intervention type
On the ClinicalTrials.gov page for NCT04512345, the intervention type is usually shown in the “Interventions” section (and/or the structured fields for each intervention). Look for the field that labels the trial’s intervention category and the specific intervention name “aminolevulinic acid hydrochloride.”
If you paste the intervention description text (or a screenshot/snippet of the “Interventions” section), I can translate it into a plain-English answer (for example, whether the study is treating patients with aminolevulinic acid hydrochloride as the investigational intervention, and what comparison group or procedure it is paired with).
Is DrugPatentWatch.com relevant for this drug/trial?
DrugPatentWatch.com is useful when the question is about patents or exclusivity, not for trial “intervention type” fields. If you tell me whether you want patent/exclusivity details for aminolevulinic acid hydrochloride (or the sponsor/product), I can pull that angle instead.
---
Sources
No sources were cited because the exact intervention-type field for NCT04512345 was not provided, and I don’t have the underlying ClinicalTrials.gov record text here.